Endothelial dysfunction: A synonym for functional atherosclerosis;Endotheliale dysfunktion: Ein synonym für funktionelle atherosklerose

Journal fur Kardiologie

Volumn 9, Issue 12, 2002, Pages 556-562

  Rösen, Peter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPTERIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTERY DISEASE; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; CELL ADHESION; CELL PROLIFERATION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLYCOSYLATION; HUMAN; LEUKOCYTE ADHERENCE; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; THROMBOCYTE ADHESION; VASCULAR ENDOTHELIUM;

EID: 0036445839     PISSN: 10240098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34.
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
4. Cubeddu LX, Hoffmann IS. Insulin resistance and upper-normal glucose levels in hypertension: A review. J Hum Hypertens 2002; 16 (Suppl 1): S52-S55.
5. Gimbrone A, Topper N. Biology of the vessel wall: Endothelium. In: Chien KR (ed). Molecular Basis of Cardiovascular Disease. W. B. Saunders, Philadelphia, 1999; 331-48.
6. Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS. Endothelial dysfunction: Cause of the insulin resistance syndrome. Diabetes 1997; 46 (Suppl 2): S9-S13.
7. Baumgartner-Parzer SM, Waldhausl WK. The endothelium as a metabolic and endocrine organ: Its relation with insulin resistance. Exp Clin Endocrinol Diabetes 2001; 109: S166-S179.
8. Ross R, Glomset JA. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med 1976; 295: 420-5.
9. Ross R, Glomset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 1976; 295: 369-77.
10. th Int. Symp on Atherosclerosis. Amsterdam, Excerpta Medica, 1986; 367-9.
11. Simionescu N, Simionescu M. Endothelial Cell Dysfunction. New York, Plenum Press, 1992.
12. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
13. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-51.
14. Ignarro LJ. Nitric oxide: A unique endogenous signaling molecule in vascular biology. Biosci Rep 1999; 19: 51-71.
15. Meredith IA, Yeung AC, Weidinger FF. Role of impaired endothelium dependent vasodilation in ischemic manifestations of coronary artery disease. Circulation 1993; 87 (Suppl V): V56-V66.
16. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 1990; 16: 349-56.
17. Taylor AA. Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus. Endocrinol Metab Clin North Am 2001; 30: 983-97.
18. Bell DS. Inflammation, insulin resistance, infection, diabetes, and atherosclerosis. Endocr Pract 2000; 6: 272-6.
19. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228-34.
20. Schächinger V, Zeiher AM. Quantitative assessment of coronary vasoreactivity in humans in vive. Importance of baseline vasomotor tone in atherosclerosis. Circulation 1995; 92: 2087-94.
21. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 2000; 101: 1899-906.
22. Baron AD. Hemodynamic actions of insulin. Am J Physiol 1994; 267: E187-E202
23. Steinberg HO, Baron AD Vascular function, insulin resistance and fatty acids. Diabetologia 2002; 45: 623-34.
24. Jagasia D, Whiting JM, Concato J, Pfau S, McNulty PH. Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease Circulation 2001; 103: 1734-9.
25. Stehouwer CD, Fischer HR, van Kuijk AW, Polak BC, Donker AJ. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 1995; 44: 561-4.
26. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 1993; 268: 12231-4.
27. Marletta MA. Another activation switch for endothelial nitric oxide synthase: Why does it have to be so complicated? Trends Biochem Sci 2001; 26: 519-21.
28. Moncada S. Nitric oxide. Hypertension 1994; 12 (10): S35-S39.
29. Igarashi J, Michel T. More sweetness than light? A search for the causes of diabetic vasculopathy. J Clin Invest 2001; 108: 1425-7.
30. Feron O, Kelly RA. The caveolar paradox: Suppressing, inducing, and terminating eNOS signaling. Circ Res 2001; 88: 129-31.
31. Schmidt HH, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta 1993; 1178: 153-75.
32. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
33. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C. Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001; 108: 1341-8.
34. Steinberg D. Role of oxidized LDL and antioxidants in atherosclerosis. Adv Exp Med Biol 1995; 369: 39-48.
35. Keaney JF Jr. Atherosclerosis: From lesion formation to plaque activation and endothelial dysfunction. Mol Aspects Med 2000; 21: 99-166.
36. Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation, Am J Cardiol 2001; 88: 3J-6J.
37. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365-72.
38. Libby P, Simon Dl. Inflammation and thrombosis: The clot thickens. Circulation 2001; 103: 1718-20.
39. Luscinskas FW, Gimbrone MA Jr. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu Rev Med 1996; 47: 413-21.
40. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709-20.
41. Rösen P, Du XL. Oxidative stress in diabetes: Why does hyperglycaemia induce the formation of reactive oxygen species? In: Packer L, Rösen P, Tritschler HJ, King GL, Azzi A (eds) Antioxidants in Diabetes Management New York, Marcel Dekker, 2000; 17-32.
42. Rösen P, Nawroth P, King GL, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications. Diabetes/Metabolism Res Rev 2001; 17: 189-212.
43. Du X, Stocklauser-Färber K, Rösen P. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: Role of nitric oxide synthase? Free Radio Biol Med 1999; 27: 752-63.
44. Tak PP, Firestein GS. NF-kappaB: A key role in inflammatory diseases. J Clin Invest 2001; 107: 7-11.